Horizon Therapeutics PLC's orphan drug TEPEZZA is helping +4,000 people with thyroid eye disease
Research and development (R&D) investments play a key role in developing diagnostics, drugs, and vaccines that improve and save people's lives while enhancing their health security1. Thyroid eye disease, also known as Graves’ eye disease, is a r...
Register to read the full analysis —or— Upgrade to access more features
#IMPACT
#IMPAAKT
#TEPEZZA
#rare eye diseases
#EYES
#HORIZON THERAP
Actual Direct Impact
Share this Analysis
Keen to rectify an issue with this analysis?
Report issue
There is no comment yet.